Catalog No.:AA00BDNB

2564-02-5 | N-(4-Bromophenyl)-2-chloroacetamide

Name: Name:N-(4-Bromophenyl)-2-chloroacetamide
Brand: AABLOCKS
SKU: AA00BDNB
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

95%

in stock

$55.00 $39.00

- +

95%

in stock

$153.00 $107.00

- +

25g

97%(HPLC)

in stock

$724.00 $507.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00BDNB

Chemical Name:

N-(4-Bromophenyl)-2-chloroacetamide

CAS Number:

2564-02-5

Molecular Formula:

C8H7BrClNO

Molecular Weight:

248.5043

MDL Number:

MFCD00018903

SMILES:

ClCC(=O)Nc1ccc(cc1)Br

NSC Number:

220248

Properties

Computed Properties

Complexity:

157

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

2.3

Downstream Synthesis Route

79-04-9

106-40-1

2564-02-5

[1]Patent:WO2013/148333,2013,A1.Locationinpatent:Paragraph0089

[2]Synthesis,2018,vol.50,p.2041-2057

[3]BioorganicandMedicinalChemistry,2007,vol.15,p.2514-2527

[4]JournalofMedicinalChemistry,2011,vol.54,p.2060-2068

[5]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.2003-2010

[6]EuropeanJournalofMedicinalChemistry,2019,vol.164,p.193-213

[7]DyesandPigments,2013,vol.99,p.779-786

[8]JournaloftheBrazilianChemicalSociety,2019,vol.30,p.188-197

[9]JournalofMolecularStructure,2019,vol.1198

[10]PharmaceuticalChemistryJournal,1981,vol.15,p.849-853 Khimiko-FarmatsevticheskiiZhurnal,1981,vol.15,p.23-26

[11]Patent:US2019/15380,2019,A1.Locationinpatent:Paragraph0013;0127

[12]EuropeanJournalofMedicinalChemistry,2014,vol.80,p.83-91

[13]EuropeanJournalofMedicinalChemistry,2012,vol.53,p.390-397

[14]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.4154-4156

[15]EuropeanJournalofMedicinalChemistry,2012,vol.53,p.41-51

[16]MedicinalChemistryResearch,2013,vol.22,p.195-210

[17]EuropeanJournalofMedicinalChemistry,2020,vol.198

[18]CellChemicalBiology,2019,vol.26,p.1027-22,1035

[19]Patent:US2013/230542,2013,A1.Locationinpatent:Paragraph0135

[20]BioorganicandMedicinalChemistry,2014,vol.22,p.5378-5391

[21]ArchivderPharmazie,1903,vol.241,p.210

[22]BulletindelaSocieteChimiquedeFrance,1902,vol.<3>27,p.542

[23]JournaloftheAmericanChemicalSociety,1933,vol.55,p.3859,3862

[24]JournalofOrganicChemistry,1962,vol.27,p.4382-4385

[25]CollectionofCzechoslovakChemicalCommunications,1993,vol.58,p.2211-2214

[26]MagneticResonanceinChemistry,2000,vol.38,p.384-385

[27]BioorganicandMedicinalChemistry,2006,vol.14,p.4820-4833

[28]JournalofAgriculturalandFoodChemistry,2006,vol.54,p.6800-6808

[29]JournalofOrganicChemistry,2009,vol.74,p.2846-2849

[30]EuropeanJournalofMedicinalChemistry,2010,vol.45,p.3504-3510

[31]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.4661-4664

[32]AsianJournalofChemistry,2011,vol.23,p.2648-2652

[33]E-JournalofChemistry,2011,vol.8,p.635-642

[34]MedicinalChemistryResearch,2011,vol.20,p.152-157

[35]ChemicalBiologyandDrugDesign,2011,vol.78,p.309-313

[36]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2013,vol.52,p.568-572

[37]RussianChemicalBulletin,2012,vol.61,p.2311-2321 Izv.Akad.Nauk,Ser.Khim.,2012,p.2290-2300,11

[38]BioorganicandMedicinalChemistry,2013,vol.21,p.6973-6980

[39]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.2613-2616

[40]MedicinalChemistry,2013,vol.9,p.596-607

[41]JournalofChemicalResearch,2014,vol.38,p.611-616

[42]AsianJournalofChemistry,2015,vol.27,p.491-495

[43]EuropeanJournalofMedicinalChemistry,2015,vol.92,p.401-414

[44]EuropeanJournalofMedicinalChemistry,2015,vol.93,p.321-329

[45]RSCAdvances,2015,vol.5,p.48368-48381

[46]ChemistryofNaturalCompounds,2015,vol.51,p.620-625 Khim.Prir.Soedin.,2015,vol.51,p.536-540,5

[47]Lettersindrugdesignanddiscovery,2015,vol.12,p.529-536

[48]RSCAdvances,2016,vol.6,p.27885-27895

[49]EuropeanJournalofMedicinalChemistry,2016,vol.121,p.58-70

[50]MedicinalChemistry,2016,vol.12,p.631-639

[51]JournaloftheBrazilianChemicalSociety,2016,vol.27,p.1807-1813

[52]TetrahedronLetters,2017,vol.58,p.190-193

[53]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2016,vol.55B,p.374-380

[54]JournalofSulfurChemistry,2017,vol.38,p.43-51

[55]Arkivoc,2017,vol.2017,p.316-325

[56]InternationalJournalofPharmacyandPharmaceuticalSciences,2017,vol.9,p.226-232

[57]EuropeanJournalofMedicinalChemistry,2018,vol.145,p.350-359

[58]ChemicalPapers,2018,vol.72,p.651-659

[59]BioorganicChemistry,2018,vol.80,p.288-295

[60]JournalofHeterocyclicChemistry,2018,vol.55,p.1765-1774

[61]CanadianJournalofChemistry,2019,vol.97,p.94-99

[62]DrugDevelopmentResearch,2019,vol.80,p.125-132

[63]JournalofHeterocyclicChemistry,2019,vol.56,p.539-551

[64]JournalofHeterocyclicChemistry,2019

[65]EuropeanJournalofOrganicChemistry,2019,vol.2019,p.4260-4270

[66]BioorganicChemistry,2019,vol.90

[67]BioorganicandMedicinalChemistry,2019,vol.27,p.3383-3389

[68]EuropeanJournalofMedicinalChemistry,2019,vol.183

[69]BioorganicChemistry,2019,vol.93

[70]StructuralChemistry,2020,vol.31,p.999-1012

[71]BioorganicChemistry,2019

[72]BioorganicChemistry,2020,vol.95

[73]BioorganicChemistry,2020,vol.95

[74]TetrahedronLetters,2020

[75]BioorganicChemistry,2020,vol.100

4-(pyridin-2-yl)piperidinehydrochloride

2564-02-5

N-(4-bromophenyl)-2-4-(2-pyridinyl)-1-piperidinylacetamidetrifluoroaceticsalt

[1]Patent:US2003/229094,2003,A1.Locationinpatent:Page75

123-75-1

2564-02-5

89473-71-2

[1]Patent:WO2007/146758,2007,A2.Locationinpatent:Page/Pagecolumn82

[2]Patent:US6025382,2000,A

38941-98-9

2564-02-5

1134193-60-4

[1]JournalofOrganicChemistry,2009,vol.74,p.2846-2849

75-15-0

2185-03-7

2564-02-5

1446270-26-3

[1]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.4154-4156

[2]EuropeanJournalofMedicinalChemistry,2015,vol.93,p.321-329

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS